Migraine-Relief
Natural health product licensed in Canada
- Other names
- MigrainePro, MigraineX, Migrainelief
- Licence holder
- Naturo Aid Pharmaceutical Inc.
- NPN or DIN-HM
- 80078582
- Status
- Active licence
- Licence date
- 21 June 2017
- Revision date
- 19 July 2017
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Riboflavine Source : Riboflavine | 30 milligramme | 90,000 µg |
| Petasites hybridus Source : Racine Potency : 15 % Petasins | 50 milligramme | Not calculated |
| Tanacetum parthenium Source : Sommité Potency : 0.8 % Parthenolide | 50 milligramme | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Microorganismes CoQ10 - Cellule entière pour biosynthèse | 75 milligramme | Not calculated |
| Zingiber officinale Source : Zingiber officinale - Rhizome Extract : Matériel brut sec Extraction ratio : 25:1 Dry plant equivalent : 1,000 milligramme | 40 milligramme | Not calculated |
| Salix alba Source : Jeune écorce de branche Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,000 milligramme Potency : 15 % Salicin | 100 milligramme | Not calculated |
| L-5-hydroxytryptophane Source : 5-HTP de Griffonia simplicifolia (Graines) | 100 milligramme | Not calculated |
Non-medicinal ingredients
L-Leucine, Hypromellose, Dioxyde de silicium, Pullulane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 days |
Uses authorised in Canada
Helps to reduce the frequency of migraine headaches and associated nausea and vomiting when taken as a prophylactic. Willow bark is traditionally used in Herbal Medicine to relieve headache pain. Helps to reduce the severity and duration of migraine headaches when taken as a prophylactic. (Clinically shown to) help(s) prevent nausea and vomiting associated with motion sickness, and/or seasickness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if migraine frequency increases, and associated nausea and vomiting persist or worsen. Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care practitioner prior to use if you are taking blood pressure medication. Consult a health care practitioner prior to use if you are taking carbidopa or drugs/supplements with serotonergic activity. These may include, but are not limited to, L-tryptophan, S-adenosylmethionine (SAMe), St. John's wort, antidepressants, pain killers, over the counter cough and cold medication containing dextromethorphan, anti-nausea medication and anti-migraine medication. Discontinue use and consult a health care practitioner if you show signs of weakness, oral ulcers, or abdominal pain accompanied by severe muscle pain or if you experience skin changes. If you experience gastrointestinal symptoms such as nausea, vomiting, abdominal pain, dyspepsia, heartburn or diarrhea, discontinue use and consult a health care practitioner. If you have asthma or peptic ulcer disease, consult a health care practitioner prior to use. If you are taking anticoagulants or products containing acetylsalicylic acid (ASA) or other salicylates, consult a health care practitioner prior to use. Discontinue use and consult a health care practitioner if any of the following symptoms occur: upper right abdominal pain, nausea, vomiting, jaundice and/or hepatitis.
- Effets indésirables connus
Hypersensitivity, such as an allergy, has been known to occur; in which case, discontinue use. Some people may experience sore mouth, mouth ulcers and/or gastrointestinal discomfort. Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness.
- Contre-indications
Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family. If you are pregnant or breastfeeding, do not use this product. Do not use if you have scleroderma. If you are allergic to acetylsalicylic acid (ASA) or other salicylates, do not use this product. Do not use if you have a liver disease.
Source
Official Health Canada record, licence 80078582
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging